Goldman Myla Lai West Pharmaceutical Services Inc (WST) insider trading activity

WST Quotes by TradingView

Goldman Myla Lai is Director of WEST PHARMACEUTICAL SERVICES INC. Currently has a direct ownership of 18,352 shares of WST, which is worth approximately $5.81 Million. The most recent transaction as insider was on Apr 23, 2024, when has been sold 564 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.4K
0% 3M change
3.17% 12M change
Total Value Held $5.81 Million

GOLDMAN MYLA LAI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 23 2024
BUY
Grant, award, or other acquisition
-
564 Added 2.98%
18,352 Common Stock
Apr 25 2023
BUY
Grant, award, or other acquisition
-
616 Added 3.35%
17,788 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
632 Added 3.55%
17,172 Common Stock
May 04 2021
BUY
Grant, award, or other acquisition
-
577 Added 3.37%
16,540 Common Stock

Also insider at

AKYA
Akoya Biosciences, Inc. Healthcare
Director
GML

Goldman Myla Lai

Director
Exton, PA

Track Institutional and Insider Activities on WST

Follow WEST PHARMACEUTICAL SERVICES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on WST